INS and type 1 diabetes mellitus: The strength of our findings is in demonstrating the glycaemic control benefit from use of flash sensor technology by MDI therapy users with type 1 diabetes, indicating the improvement is associated with the information provided by the technology not a specific insulin treatment modality.